UA92423C2 - Антибактериальная композиция - Google Patents

Антибактериальная композиция

Info

Publication number
UA92423C2
UA92423C2 UAA200907781A UAA200907781A UA92423C2 UA 92423 C2 UA92423 C2 UA 92423C2 UA A200907781 A UAA200907781 A UA A200907781A UA A200907781 A UAA200907781 A UA A200907781A UA 92423 C2 UA92423 C2 UA 92423C2
Authority
UA
Ukraine
Prior art keywords
antibacterial composition
fluoroquinolone
diseases
pasterellosis
colibacteriosis
Prior art date
Application number
UAA200907781A
Other languages
English (en)
Ukrainian (uk)
Inventor
Анатолій Альбертович Кузьмін
Олександр Миколайович Боровко
Original Assignee
Анатолій Альбертович Кузьмін
Олександр Миколайович Боровко
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Анатолій Альбертович Кузьмін, Олександр Миколайович Боровко filed Critical Анатолій Альбертович Кузьмін
Priority to UAA200907781A priority Critical patent/UA92423C2/ru
Priority to PCT/IB2009/054349 priority patent/WO2011010190A1/en
Priority to EA200970881A priority patent/EA017028B1/ru
Publication of UA92423C2 publication Critical patent/UA92423C2/ru

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/436—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system containing a six-membered ring having oxygen as a ring hetero atom, e.g. rapamycin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/437—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system containing a five-membered ring having nitrogen as a ring hetero atom, e.g. indolizine, beta-carboline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/4709—Non-condensed quinolines and containing further heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/496—Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene or sparfloxacin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
    • A61K31/5375—1,4-Oxazines, e.g. morpholine
    • A61K31/5383—1,4-Oxazines, e.g. morpholine ortho- or peri-condensed with heterocyclic ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/12—Carboxylic acids; Salts or anhydrides thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Medicinal Preparation (AREA)

Abstract

Изобретение относится к ветеринарной медицине, в частности, к препаратам, предназначенным для профилактики и лечения инфекционных заболеваний, например, сальмонеллеза, колибактериоза, пастереллеза и других заболеваний. Антибактериальная композиция содержит как минимум один фторхинолон или одну фармацевтически приемлемую соль фторхинолона, триметоприм, вспомогательные вещества, органическую кислоту и воду.
UAA200907781A 2009-07-24 2009-07-24 Антибактериальная композиция UA92423C2 (ru)

Priority Applications (3)

Application Number Priority Date Filing Date Title
UAA200907781A UA92423C2 (ru) 2009-07-24 2009-07-24 Антибактериальная композиция
PCT/IB2009/054349 WO2011010190A1 (en) 2009-07-24 2009-10-05 Antibacterial composition comprising fluoroquinlone such as norfloxacin together with tripmethoprim
EA200970881A EA017028B1 (ru) 2009-07-24 2009-10-21 Антибактериальная композиция

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
UAA200907781A UA92423C2 (ru) 2009-07-24 2009-07-24 Антибактериальная композиция

Publications (1)

Publication Number Publication Date
UA92423C2 true UA92423C2 (ru) 2010-10-25

Family

ID=43498813

Family Applications (1)

Application Number Title Priority Date Filing Date
UAA200907781A UA92423C2 (ru) 2009-07-24 2009-07-24 Антибактериальная композиция

Country Status (3)

Country Link
EA (1) EA017028B1 (ru)
UA (1) UA92423C2 (ru)
WO (1) WO2011010190A1 (ru)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN103341167B (zh) * 2013-07-05 2015-03-18 成都乾坤动物药业有限公司 一种兽用复方醋酸溶液及其制备工艺
CN110237075A (zh) * 2019-06-25 2019-09-17 华中农业大学 一种达氟沙星在治疗副猪嗜血杆菌药物中的用途

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4331147A1 (de) * 1993-09-14 1995-03-16 Nycomed Arzneimittel Gmbh Intravenös verabreichbare, wäßrige Lösung
DK1025846T3 (da) * 1998-08-21 2006-11-06 Kyorin Seiyaku Kk Vandige flydende præparater
TW200403072A (en) * 2002-01-23 2004-03-01 Upjohn Co Combination therapy for the treatment of bacterial infections
RU2229884C2 (ru) * 2002-03-04 2004-06-10 Пятигорская государственная фармацевтическая академия Способ стабилизации раствора ципрофлоксацина для инфузий
CN1568997A (zh) * 2003-07-04 2005-01-26 吕华冲 抗菌药物协同组合物
US20100041623A1 (en) * 2006-10-12 2010-02-18 Shirou Sawa Aqueous liquid preparation comprising gatifloxacin
CN100589807C (zh) * 2007-04-28 2010-02-17 成青兰 一种复方磺胺间甲氧嘧啶钠注射液的配方及制作工艺
EP2260848A4 (en) * 2008-03-31 2013-02-13 Kyorin Seiyaku Kk WATER-CONTAINING LIQUID WITH GATIFLOXACIN, METHOD FOR THE PRODUCTION THEREOF, AND METHOD FOR PREVENTING THE DEPOSITION OF DEPOSITS DURING THE STORAGE OF THE WATER-CONTAINING LIQUID AT LOW TEMPERATURE OR WHEN FREEZING / DEFROSTING THE WATER-CONTAINING LIQUID

Also Published As

Publication number Publication date
EA017028B1 (ru) 2012-09-28
EA200970881A1 (ru) 2011-02-28
WO2011010190A1 (en) 2011-01-27

Similar Documents

Publication Publication Date Title
PH12017501306A1 (en) Inhibitors of histone demethylases
EA033311B1 (ru) Производные бензоксаборола в качестве антибактериальных средств
MX2011011854A (es) Dihidropirimidinonas para uso como inhibidores de la bace2.
MX2013006040A (es) Antagonistas del receptor de acido lisofosfatidico y su uso en el tratamiento de fibrosis.
PH12015501964A1 (en) Substituted 2-aza-bicyclo[2.2.1]heptane-3-carboxylic acid (benzyl-cyano-methyl)-amides inhibitors of cathepsin c
MX2013003634A (es) Derivados policiclicos heterociclicos y metodos de uso de los mismos para el tratamiento de enfermedades virales.
MY198204A (en) Cyclic Boronic Acid Ester Derivatives And Therapeutic Uses Thereof
MX2015007556A (es) Derivados de manosa para tratar infecciones bacterianas.
UA110199C2 (xx) Тверда дисперсія рифаксиміну
WO2011127333A3 (en) Compounds for treating disease, for administering, and for pharmaceutical compositions
PH12015500713A1 (en) Acylaminopyrimidine derivatives for the treatment of viral infections and further diseases
PH12015501609A1 (en) Phenicol antibacterials
WO2012064897A3 (en) Bicyclic and tricyclic inhibitors of sumoylation enzymes and methods for their use
PH12012501389A1 (en) Hedgehog inhibitors
NZ596628A (en) Ketolide compounds having antimicrobial activity
WO2010042212A3 (en) Methods for treating or preventing pain using spicamycin derivatives
IN2015DN02109A (ru)
MX337145B (es) Composiciones farmaceuticas.
WO2010086617A3 (en) Phosphoantigens for the treatment of burkholderia infections
UA94177C2 (en) antimicrobial composition
EA200970881A1 (ru) Антибактериальная композиция
MY171941A (en) Pharmaceutical compositions
SA515360233B1 (ar) مثبطات إنزيمات هستون ديميثيلاز
EA201200407A1 (ru) Новые терапевтические концепции лечения фибромиалгии
MD17Y (en) Method for treating stable anxious depressive states